Maximizing Pharmaceutical Licensing Opportunities

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • Oct 2014

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. Indeed, the chronic heart failure agent is believed to represent both a significant growth drive ...

Industries: Pathology | Countries: United States

Kwang Dong Pharmaceutical Company Limited

Kwang Dong Pharmaceutical Company Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 57 pages

A textual analysis of the financial results for Kwang Dong Pharmaceutical Company Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical

Wooridul Pharmaceutical Limited

Wooridul Pharmaceutical Limited

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 57 pages

A textual analysis of the financial results for Wooridul Pharmaceutical Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Pharmaceutical | Countries: South Korea

Hisamitsu Pharmaceutical Co Inc

Hisamitsu Pharmaceutical Co Inc

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 55 pages

A textual analysis of the financial results for Hisamitsu Pharmaceutical Co Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Pharmaceutical

Rekah Pharmaceutical Industry Ltd.

Rekah Pharmaceutical Industry Ltd.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 56 pages

A textual analysis of the financial results for Rekah Pharmaceutical Industry Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A ...

Industries: Pharmaceutical

Adacel Technologies Ltd

Adacel Technologies Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 54 pages

A textual analysis of the financial results for Adacel Technologies Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business description ...

Industries: Drug and Medication

Egypt International Pharmaceuticals

Egypt International Pharmaceuticals

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 55 pages

A textual analysis of the financial results for Egypt International Pharmaceuticals compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical | Countries: Egypt

United Therapeutics Corporation, Wright Investors' Service

United Therapeutics Corporation, Wright Investors' Service

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 56 pages

A textual analysis of the financial results for United Therapeutics Corporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. A business ...

Industries: Therapy

Trimurthi Drugs & Pharmaceuticals Ltd

Trimurthi Drugs & Pharmaceuticals Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 53 pages

A textual analysis of the financial results for Trimurthi Drugs & Pharmaceuticals Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Drug and Medication

Cairo Pharmaceuticals & Chem. Industries

Cairo Pharmaceuticals & Chem. Industries

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 55 pages

A textual analysis of the financial results for Cairo Pharmaceuticals & Chem. Industries compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pharmaceutical | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.